Comparative effects of ranolazine and trimetazidine on cardiac structure and exercise capacity in a healthy rat model: a new doping agent?

被引：0
|
作者：
Kilic, S. [1 ]
Torun, A. [1 ]
Asal, S. [1 ]
Demirtas, C. [2 ]
Dilmen, S. [3 ]
Cinar, T.
Orhan, A. L. [1 ]
Uzun, M. [1 ]
机构：
[1] Hlth Sci Univ, Sultan 2 Abdulhamid Han Training & Res Hosp, Cardiol, Istanbul, Turkiye
[2] Hlth Sci Univ, Hamidiye Sch Med, Physiol, Istanbul, Turkiye
[3] Izmir Bayrakli State Hosp, Cardiol, Izmir, Turkiye
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 31 条
  • [21] Exercise Capacity, Cardiac fibrosis and Left Ventricular Remodeling in a Rat Model of Chronic Pressure Overload: Serial Echocardiography, Pressure-Volume Analysis and Gene Expression Profiling
    Kim Kyung-hee
    Park, Yoonjee
    Byun, Jae Kyeong
    Rha, Seung-Woon
    CIRCULATION RESEARCH, 2019, 125
  • [22] COMPARATIVE EFFECTS OF A NEW ORALLY ACTIVE ANTIDYSRHYTHMIC AGENT, ORGANON 6001, ON CARDIAC ACTION POTENTIAL OF HUMAN VENTRICULAR MUSCLE AND SHEEP PURKINJE-FIBERS
    KANE, KA
    BRITISH JOURNAL OF PHARMACOLOGY, 1977, 61 (03) : P457 - P458
  • [23] COMPARATIVE HEALING EFFECTS OF RANITIDINE (R) AND A NON-ANTISECRETORY CYTOPROTECTIVE AGENT, BMY-26517-31 (BMY), IN A RAT CHRONIC ULCER MODEL
    CROSSWELL, AR
    QUIGLEY, MJ
    BUYNISKI, JP
    SCHWARTZ, SE
    GASTROENTEROLOGY, 1986, 90 (05) : 1383 - 1383
  • [24] Clinical and pathological effects of the magnetic resonance imaging contrast agent gadodiamide on a new, adenine-sensitized, rat model of nephrogenic systemic fibrosis
    Fretellier, N.
    Bouzian, N.
    Bruneval, P.
    Daubine, F.
    Parmentier, N.
    Idee, J.
    Corot, C.
    TOXICOLOGY LETTERS, 2011, 205 : S182 - S182
  • [25] DIFFERENTIAL CARDIAC EFFECTS OF GROWTH-HORMONE AND IGF-1 IN A NEW MODEL OF HORMONE EXCESS IN THE RAT - SERIAL IN-VIVO EVALUATION
    CITTADINI, A
    KATZ, SE
    STROMER, H
    MORGAN, JP
    DOUGLAS, PS
    CIRCULATION, 1994, 90 (04) : 17 - 17
  • [26] Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022
    Shimazawa, M
    Takiguchi, Y
    Umemura, K
    Kondo, K
    Nakashima, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 328 (2-3) : 183 - 189
  • [27] Antithrombotic effects, in a rat model of aspirin-insensitive arterial thrombosis, of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022
    Shimazawa, M
    Takiguchi, Y
    Umemura, K
    Kondo, K
    Nakashima, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2824 - P2824
  • [28] COMPARATIVE EFFECTS OF A POTASSIUM CHANNEL BLOCKING DRUG, UK-68,798, AND A SPECIFIC BRADYCARDIAC AGENT, UL-FS 49, ON EXERCISE-INDUCED ISCHEMIA IN THE DOG - SIGNIFICANCE OF DIASTOLIC TIME ON ISCHEMIC CARDIAC-FUNCTION
    GOUT, B
    JEAN, J
    BRIL, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (03): : 987 - 994
  • [29] HEMODYNAMIC-EFFECTS IN MAN DURING EXERCISE OF A SINGLE ORAL DOSE OF NARBIVOLOL (R-67555), A NEW BETA-1-ADRENOCEPTOR BLOCKING-AGENT - A COMPARATIVE-STUDY WITH ATENOLOL, PINDOLOL, AND PROPRANOLOL
    DECREE, J
    GEUKENS, H
    LEEMPOELS, J
    VERHAEGEN, H
    DRUG DEVELOPMENT RESEARCH, 1986, 8 (1-4) : 109 - 117
  • [30] Effects of exercise intensity and diet on cardiac tissue structure and FGF21/β-Klotho signaling in type 2 diabetic mice: a comparative study of HFD and HFD plus STZ induced type 2 diabetes models in mice
    Moharamzadeh, Sevda
    Kashef, Majid
    Salehpour, Mojtaba
    Torabi, Meysam
    Vesali, Samira
    Samsonchi, Zakieh
    Hajizadeh-Saffar, Ensiyeh
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
1234